Trial · NCT06323174
Registered outcomes31
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 31
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in glycated haemoglobin (HbA1c) | From baseline (week 0) to end of treatment (week 40) | Measured as percentage (%)-points. |
| Secondary | Relative change in body weight | From baseline (week 0) to end of treatment (week 40) | Measured in %. |
| Secondary | Number of participants who achieve greater than or equal to (>=) 10% body weight reduction | From baseline (week 0) to end of treatment (week 40) | Measured as count of participants. |
| Secondary | Number of participants who achieve >=15% body weight reduction | From baseline (week 0) to end of treatment (week 40) | Measured as count of participants. |
| Secondary | Number of participants who achieve HbA1c target values of less than (<) 7.0% (<53 millimoles per mole [mmol/mol]) | At end of treatment (week 40) | Measured as count of participants. |
| Secondary | Number of participants who achieve HbA1c target values of less than or equal to (<=) 6.5% (<= 48 mmol/mol) | At end of treatment (week 40) | Measured as count of participants. |
| Secondary | Change in Fasting Plasma Glucose (FPG) | From baseline (week 0) to end of treatment (week 40) | Measured in millimoles per liter (mmol/L). |
| Secondary | Number of participants who achieve >=5% body weight reduction | From baseline (week 0) to end of treatment (week 40) | Measured as count of participants. |
| Secondary | Number of participants who achieve >=20% body weight reduction | From baseline (week 0) to end of treatment (week 40) | Measured as count of participants. |
| Secondary | Change in waist circumference | From baseline (week 0) to end of treatment (week 40) | Measured in centimeters (cm). |
| Secondary | Change in systolic blood pressure (SBP) | From baseline (week 0) to end of treatment (week 40) | Measured in millimeters of mercury (mmHg). |
| Secondary | Change in diastolic blood pressure (DBP) | From baseline (week 0) to end of treatment (week 40) | Measured in mmHg. |
| Secondary | Ratio to baseline in high sensitivity C-reactive protein (hsCRP) | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Total cholesterol | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: High-density lipoprotein (HDL) cholesterol | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Low-density lipoprotein (LDL) cholesterol | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Very low-density lipoprotein (VLDL) cholesterol | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Triglycerides | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Free fatty acids | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
| Secondary | Ratio to baseline in lipids: Non-HDL cholesterol | From baseline (week 0) to end of treatment (week 40) | Measured as ratio. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06323174/registered